Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden

H. Thomsen, X. Li, K. Sundquist, J. Sundquist, A. Försti, K. Hemminki

. 2020 ; 10 (1) : 20887. [pub] 20201130

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21011830

Giant cell arteritis (GCA, also called temporal arteritis) is a rare and Takayasu arteritis (TA) is an even rarer autoimmune disease (AID), both of which present with inflammatory vasculitis of large and medium size arteries. The risk factors are largely undefined but disease susceptibility has been associated with human leukocyte antigen locus. Population-level familial risk is not known. In the present nation-wide study we describe familial risk for GCA and for GCA and TA with any other AID based on the Swedish hospital diagnoses up to years 2012. Family relationships were obtained from the Multigeneration Register. Familial standardized incidence ratios (SIRs) were calculated for offspring whose parents or siblings were diagnosed with GCA, TA or any other AID. The number of GCA patients in the offspring generation was 4695, compared to 209 TA patients; for both, familial patients accounted for 1% of all patients. The familial risk for GCA was 2.14, 2.40 for women and non-significant for men. GCA was associated with 10 other AIDs and TA was associated with 6 other AIDs; both shared associations with polymyalgia rheumatica and rheumatoid arthritis. The results showed that family history is a risk factor for GCA. Significant familial associations of both GCA and TA with such a number of other AIDs provide evidence for polyautoimmunity among these diseases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21011830
003      
CZ-PrNML
005      
20210507104443.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-020-77857-7 $2 doi
035    __
$a (PubMed)33257751
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Thomsen, Hauke $u Division of Molecular Genetic Epidemiology, German Cancer Research Centre (DKFZ), 69120, Heidelberg, Germany. hauke.thomsen@genewerk.de $u Center for Primary Health Care Research, Lund University, Malmö, Sweden. hauke.thomsen@genewerk.de $u GeneWerk GmbH, Im Neuenheimer Feld 582, 69120, Heidelberg, Germany. hauke.thomsen@genewerk.de
245    10
$a Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden / $c H. Thomsen, X. Li, K. Sundquist, J. Sundquist, A. Försti, K. Hemminki
520    9_
$a Giant cell arteritis (GCA, also called temporal arteritis) is a rare and Takayasu arteritis (TA) is an even rarer autoimmune disease (AID), both of which present with inflammatory vasculitis of large and medium size arteries. The risk factors are largely undefined but disease susceptibility has been associated with human leukocyte antigen locus. Population-level familial risk is not known. In the present nation-wide study we describe familial risk for GCA and for GCA and TA with any other AID based on the Swedish hospital diagnoses up to years 2012. Family relationships were obtained from the Multigeneration Register. Familial standardized incidence ratios (SIRs) were calculated for offspring whose parents or siblings were diagnosed with GCA, TA or any other AID. The number of GCA patients in the offspring generation was 4695, compared to 209 TA patients; for both, familial patients accounted for 1% of all patients. The familial risk for GCA was 2.14, 2.40 for women and non-significant for men. GCA was associated with 10 other AIDs and TA was associated with 6 other AIDs; both shared associations with polymyalgia rheumatica and rheumatoid arthritis. The results showed that family history is a risk factor for GCA. Significant familial associations of both GCA and TA with such a number of other AIDs provide evidence for polyautoimmunity among these diseases.
650    _2
$a revmatoidní artritida $x etiologie $7 D001172
650    _2
$a autoimunitní nemoci $x etiologie $7 D001327
650    _2
$a rodina $7 D005190
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $x etiologie $7 D020022
650    _2
$a obrovskobuněčná arteritida $x etiologie $7 D013700
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a anamnéza $7 D008487
650    _2
$a polymyalgia rheumatica $x etiologie $7 D011111
650    _2
$a riziko $7 D012306
650    _2
$a Takayasuova arteriitida $x etiologie $7 D013625
651    _2
$a Švédsko $7 D013548
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Li, Xinjun $u Center for Primary Health Care Research, Lund University, Malmö, Sweden
700    1_
$a Sundquist, Kristina $u Center for Primary Health Care Research, Lund University, Malmö, Sweden $u Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA $u Department of Functional Pathology, School of Medicine, Center for Community-Based Healthcare Research and Education (CoHRE), Shimane University, Matsue, Japan
700    1_
$a Sundquist, Jan $u Center for Primary Health Care Research, Lund University, Malmö, Sweden $u Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA $u Department of Functional Pathology, School of Medicine, Center for Community-Based Healthcare Research and Education (CoHRE), Shimane University, Matsue, Japan
700    1_
$a Försti, Asta $u Division of Molecular Genetic Epidemiology, German Cancer Research Centre (DKFZ), 69120, Heidelberg, Germany $u Center for Primary Health Care Research, Lund University, Malmö, Sweden $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Centre (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany
700    1_
$a Hemminki, Kari $u Division of Molecular Genetic Epidemiology, German Cancer Research Centre (DKFZ), 69120, Heidelberg, Germany $u Center for Primary Health Care Research, Lund University, Malmö, Sweden $u Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), 69120, Heidelberg, Germany $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 10, č. 1 (2020), s. 20887
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33257751 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507104441 $b ABA008
999    __
$a ok $b bmc $g 1650259 $s 1132209
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 1 $d 20887 $e 20201130 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace